Dr Reddy’s At One-Month High On Arm Buying British Nicotine Gum Brand

Shares of Dr Reddy's Laboratories Ltd. hit the highest level in over a month on Thursday after its subsidiary signed a definitive agreement to acquire British firm Haleon Plc's consumer healthcare brand of nicotine replacement therapy for £500 million. Dr Reddy's Laboratories SA will acquire Northstar Switzerland SARL, which consists of Nicotinell, a global leader in the NRT category.